What Jim Carroll was exploring
Recorded 2026-09-16. At Genentech, a member of the Roche Group, I addressed 550 executives in San Francisco and challenged them to think beyond breakthrough science toward the broader reinvention made possible by exponential genomics.
Archive status
This record preserves a dated excerpt. A contemporary assessment has not been added because the complete historical text and independent current evidence have not yet been verified.
Original archive reference
Keynote Case Study: Genentech: Personalized Medicine Is Moving From Possibility To Platform. (2026-09-16)